Iohexol API Market

Iohexol was first listed in Norway and Sweden in 1982. It is a kind of second-generation non-ionic monomeric contrast agent. Iopromide, Iomeprol, etc. Iohexol has low osmotic pressure, low toxicity to the nervous system, low contrast density, and good tolerance. It can be used for angiography, subarachnoid angiography, coronary angiography, spinal cord and femoral joints, urology angiography, and enhanced CT scanning. Etc., is the "gold standard" for evaluating various X-ray contrast agents in the medical community.
Iohexol API Market aims to provide a comprehensive presentation of the global market for Iohexol API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Iohexol API. Iohexol API Market contains market size and forecasts of Iohexol API in global, including the following market information:
Global Iohexol API Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Iohexol API Market Sales, 2018-2023, 2024-2029, (Tons)
Global top five Iohexol API companies in 2022 (%)
The global Iohexol API market was valued at US$ 520.8 million in 2022 and is projected to reach US$ 815.3 million by 2029, at a CAGR of 6.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key manufacturers of Iohexol API include GE Healthcare, Otsuka Chemicals, Starry, etc. Global top three manufacturers hold a share about 85%. Europe is the largest market of Iohexol API, holds a share over 60%. In terms of product, the Original Drug holds a larger segment, with a share over 80%. And in terms of application, the largest application is Hospitals, with a share of over 90%.
We surveyed the Iohexol API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Iohexol API Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Iohexol API Market Segment Percentages, by Type, 2022 (%)
Original Drug
Generic Drug
Global Iohexol API Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Iohexol API Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Global Iohexol API Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Iohexol API Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Iohexol API revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Iohexol API revenues share in global market, 2022 (%)
Key companies Iohexol API sales in global market, 2018-2023 (Estimated), (Tons)
Key companies Iohexol API sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GE Healthcare
Otsuka Chemicals
Justesa Imagen
Starry Pharmaceutical
Haichang Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Iohexol API, market overview.
Chapter 2: Global Iohexol API market size in revenue and volume.
Chapter 3: Detailed analysis of Iohexol API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Iohexol API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Iohexol API capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.